As of December 2024, Getein Biotech has a market cap of $596.44M. This makes Getein Biotech the world's 10660th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $605.48M | -20.82% |
2023 | $764.67M | -12.00% |
2022 | $868.94M | -12.76% |
2021 | $996.05M | -17.95% |
2020 | $1.21B | 48.50% |
2019 | $817.51M | 21.45% |
2018 | $673.11M | -37.98% |
2017 | $1.09B | - |